Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026)
Repligen (RGEN) posted quarterly Depreciation & Amortization (CF) of $19.1 million for Q2 2026, down 5.07% year-over-year from $20.1 million in Q2 2025, and down 3.54% quarter-over-quarter from $19.8 million in Q1 2026.
Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $19.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) fell 5.07% year-over-year to $19.1 million; the TTM figure through Jun 2026 stood at $78.8 million (up 5.65% YoY), while the FY2025 annual figure was $78.7 million, up 13.02% from the prior year.
- Depreciation & Amortization (CF) declined to $19.1 million in Q2 2026 per RGEN's latest filing, from $19.8 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $20.1 million in Q2 2025 and bottomed at $11.8 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $17.0 million across 5 years, with a median of $17.3 million in 2023.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) soared 56.42% — and 2024, when it dropped 12.11%.
- Repligen's Depreciation & Amortization (CF) stood at $14.4 million in 2022, then grew by 20.03% to $17.3 million in 2023, then climbed by 6.41% to $18.4 million in 2024, then rose by 8.62% to $20.0 million in 2025, then declined by 4.46% to $19.1 million in 2026.
- Business Quant data shows RGEN's Depreciation & Amortization (CF) at $19.1 million in Q2 2026, $19.8 million in Q1 2026, and $20.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 19.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.06 Mn |
| Jun 30, 2026 | 19.06 Mn |
| Mar 31, 2026 | 19.76 Mn |
| Mar 31, 2026 | 19.76 Mn |
| Dec 31, 2025 | 19.95 Mn |
| Dec 31, 2025 | 19.95 Mn |
| Sep 30, 2025 | 20.01 Mn |
| Sep 30, 2025 | 20.01 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Mar 31, 2025 | 18.70 Mn |
| Mar 31, 2025 | 18.70 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Mar 31, 2024 | 16.91 Mn |